Phase 3 COVID-19 Respiratory Infection Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 2Phase 3
Multicenter Randomized Double-blind Placebo-controlled Study to Investigate Azvudine in Symptomatic Adults With COVID-19 at Increased Risk of Progressing to Severe Illness
COVID-19 Respiratory Infection
Peking Union Medical College Hospital1,096 enrolled1 locationNCT05689034
Recruiting
Phase 2Phase 3
Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia
COVID-19 pneumoniaCOVID-19 Respiratory Infection
KARE Biosciences324 enrolled7 locationsNCT05706454
Terminated
Phase 3
Impact of Colchicine To Improve long-COVID-19 or ARDS Outcomes
COVID-19 Respiratory Infection
University of Sydney1,000 enrolled2 locationsACTRN12621000637842